Hologic’s Cynosure division has signed an exclusive distribution agreement to distribute Porter Instrument's nitrous oxide and oxygen system Nitronox, in the US and Canada.
Cynosure is the first medical aesthetic manufacturer to offer a nitrous oxide and oxygen system to its customers.
Nitronox is a self-administered nitrous oxide and oxygen delivery system providing a fast-acting inhaled analgesic that helps patients manage potential discomfort and anxiety while remaining alert and conscious during their aesthetic procedures.
Nitrous oxide and oxygen have been used safely and effectively for more than 100 years for pain management. More recently, Nitronox devices’ non-invasive delivery system has developed a strong track record in labor and delivery as well as in outpatient medical settings.
Hologic’s Division President, Cynosure Kevin Thornal said: “We are very excited to partner Porter Instrument’s longstanding leadership and innovation in the nitrous oxide category with our market-leading medical aesthetics offerings. This agreement allows us to provide our existing and future customers a distinct competitive advantage: an unparalleled, more comfortable patient experience.”
Porter Instrument business Parker’s precision fluidics division general manager Jay Reidy said: “We are excited to partner with Cynosure, a leader within the medical aesthetic market. Our gas delivery products provide an ideal solution for pain management and patient anxiety during various procedures. Combined with the strength of Cynosure’s commercial and service teams, this will be a winning combination for both physicians and patients.”
Hologic anticipates that Nitronox will be used to complement hair removal, tattoo removal, body contouring and skin revitalization procedures.
Source: Company Press Release.